Search
for
Sort by
Research 151–180 of 1000+
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- A review of Janus kinase inhibitor use in scarring alopecia
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Abstracts from the 2024 WDS Forum - virtual option
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Skin Biology and Ageing
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review